Changes in Plasma Remimazolam Concentrations During Cardiac Surgery with Cardiopulmonary Bypass: A Prospective Study

Changes in Plasma Remimazolam Concentrations During Cardiac Surgery with Cardiopulmonary Bypass: A Prospective Study - Changes in Plasma Remimazolam Concentrations During Cardiac Surgery with Cardiopulmonary Bypass: A Prospective Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061214

Enrollment

Registered

2026-04-10

Start date

2026-05-07

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing cardiac surgery using cardiopulmonary bypass

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing elective cardiac surgery with cardiopulmonary bypass Patients aged 18 years or older at the time of obtaining informed consent Patients who have sufficient capacity to understand the study and from whom written informed consent has been obtained

Exclusion criteria

Exclusion criteria: Emergency surgery Major vascular surgery Redo surgery Patients with a known allergy to remimazolam

Design outcomes

Primary

Measure	Time frame
Changes in Plasma Remimazolam Concentrations	—

Countries

Japan

Contacts

Public Contactmasaki yoshida

wakayama medical university hospital clinical engineering center

y-masaki@wakayama-med.ac.jp073-447-2300

Outcome results